In last trading session, PAVmed Inc (NASDAQ:PAVM) saw 0.44 million shares changing hands with its beta currently measuring 1.13. Company’s recent per share price level of $0.60 trading at -$0.06 or -9.83% at ring of the bell on the day assigns it a market valuation of $9.99M. That closing price of PAVM’s stock is at a discount of -305.0% from its 52-week high price of $2.43 and is indicating a premium of 5.0% from its 52-week low price of $0.57. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.15 million shares which gives us an average trading volume of 170.70K if we extend that period to 3-months.
PAVmed Inc (NASDAQ:PAVM) trade information
Upright in the red during last session for losing -9.83%, in the last five days PAVM remained trading in the red while hitting it’s week-highest on Monday, 03/31/25 when the stock touched $0.60 price level, adding 19.39% to its value on the day. PAVmed Inc’s shares saw a change of -5.18% in year-to-date performance and have moved -20.67% in past 5-day. PAVmed Inc (NASDAQ:PAVM) showed a performance of -11.19% in past 30-days. Number of shares sold short was 0.27 million shares which calculate 1.42 days to cover the short interests.
PAVmed Inc (PAVM) estimates and forecasts
This year revenue growth is estimated to rise 325.21% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 20k for the same. And 1 analysts are in estimates of company making revenue of 20k in the next quarter. Company posted 1.01M and 976k of sales in current and next quarters respectively a year earlier.
PAVmed Inc (NASDAQ:PAVM)’s Major holders
Insiders are in possession of 23.32% of company’s total shares while institution are holding 6.37 percent of that, with stock having share float percentage of 8.31%. Investors also watch the number of corporate investors in a company very closely, which is 6.37% institutions for PAVmed Inc that are currently holding shares of the company.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 79.69 shares of worth $47414.0 or 0.47% of the total outstanding shares. The later fund manager was in possession of 50.49 shares on Feb 28, 2025 , making its stake of worth around $30040.0 in the company or a holder of 0.30% of company’s stock.
